Skip to Content

QuilliChew ER Approval History

FDA Approved: Yes (First approved December 7, 2015)
Brand name: QuilliChew ER
Generic name: methylphenidate hydrochloride
Dosage form: Extended Release Chewable Tablets
Company: Pfizer Inc.
Treatment for: ADHD

QuilliChew ER (methylphenidate hydrochloride) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Development History and FDA Approval Process for QuilliChew ER

DateArticle
Dec  7, 2015Approval Pfizer Receives FDA Approval for QuilliChew ER (methylphenidate hydrochloride) Extended-Release Chewable Tablets

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide